Zurich Cantonal Bank
NWBO

Zurich Cantonal Bank’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Zurich Cantonal Bank’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-300
Closed – – 2621
2016
Q3 		$0 Hold
300
– – ﹤0.01% 2618
2016
Q2 		$0 Sell
300
-1,416
-83% -$1.51K ﹤0.01% 2615
2016
Q1 		$3K Sell
1,716
-105,007
-98% -$207K ﹤0.01% 2552
2015
Q4 		$342K Buy
106,723
+4,162
+4% +$20K ﹤0.01% 889
2015
Q3 		$641K Buy
+102,561
New +$959K 0.01% 787

Other funds holding NWBO

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
CDH
Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
MBT
Montecito Bank & Trust Santa Barbara, California $668M AUM 24.84% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BW
Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

Zurich Cantonal Bank's NWBO Position: Q4 2016 in Review

Zurich Cantonal Bank sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2016, closing a stake of 300 shares.

Zurich Cantonal Bank first reported a position in NWBO in Q3 2015 and held it in 5 quarters. The position peaked at $641K in Q3 2015. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

  • Zurich Cantonal Bank reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2016 after selling out during the quarter.
  • Zurich Cantonal Bank sold 300 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2016.
  • Zurich Cantonal Bank first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q3 2015 and held it in 5 quarters.
  • Zurich Cantonal Bank's Northwest Biotherapeutics, Inc. Common stock position peaked at $641K in Q3 2015.
  • 8 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2016.

Based on Zurich Cantonal Bank's 13F filing for Q4 2016, filed 10 Feb 2017.